Macrophages and angiogenesis in human lymphomas

Abstract A link exists between chronic inflammation and cancer and immune cells, angiogenesis, and tumor progression. In hematologic malignancies, tumor-associated macrophages (TAMs) are a significant part of the tumor microenvironment. Macrophages are classified into M1/classically activated and M2/alternatively activated. In tumors, TAMs are mainly constituted by M2 subtype, which promotes angiogenesis, lymphangiogenesis, repair, and remodeling, suppressing adaptive immunity, increasing tumor cell proliferation, drug resistance, histological malignancy, and poor clinical prognosis. The aim of our review article is to define the role of TAMs and their relationship with the angiogenesis in patients with lymphoma reporting both an analysis of main published data and those emerging from our studies. Finally, we have discussed the anti-angiogenic approach in the treatment of lymphomas..

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:24

Enthalten in:

Clinical and experimental medicine - 24(2024), 1 vom: 29. Jan.

Sprache:

Englisch

Beteiligte Personen:

Ribatti, Domenico [VerfasserIn]
Tamma, Roberto [VerfasserIn]
Annese, Tiziana [VerfasserIn]
Ingravallo, Giuseppe [VerfasserIn]
Specchia, Giorgina [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Angiogenesis
Anti-angiogenesis
Lymphoma
Tumor-associated macrophages

Anmerkungen:

© The Author(s) 2024

doi:

10.1007/s10238-023-01291-y

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

SPR054559243